Carnathan G W, Sweeney D M, Travis J J, Gordon R J, Sutherland C A, Jariwala N, Clearfield M, O'Rourke S, Huang F C, Van Inwegen R G
Department of Immunobiology, Rorer Central Research, King of Prussia, PA 19406.
Agents Actions. 1989 Nov;28(3-4):204-11. doi: 10.1007/BF01967402.
The generation of leukotrienes C4, D4 and E4 from arachidonic acid is dependent upon the activity of 5-lipoxygenase (5-LOX). The effects of RG 6866 (N-methyl-4-benzyloxyphenylacetohydroxamic acid) on the activity of guinea pig 5-LOX in vitro and in vivo were determined in the present study. The generation of 5-hydroxy-6,8,11,14-eicosatetraenoic acid (5-HETE) from arachidonic acid by isolated guinea pig peritoneal polymorphonuclear (PMN) cells was inhibited by incubation with RG 6866 (IC50 = 0.20 microM). A similar effect (IC50 = 0.23 microM) was observed when 5-HETE production was measured in a supernatant fraction from PMNs. Additionally, the compound did not inhibit 3H-LTD4 binding to guinea pig membranes. In actively sensitized guinea pigs pretreated with indomethacin, propranolol and pyrilamine, RG 6866 inhibited antigen-induced systemic anaphylaxis and LTD4-dependent bronchoconstriction in a dose-dependent manner following oral administration. In the pulmonary anaphylaxis model, significant (p less than 0.05) inhibition of the mortality was observed within 30 min and maintained through four hours after treatment with RG 6866 (50 mg/kg i.g.). Finally, orally administered RG 6866 inhibited the formation of LTC4 in these animals with an ED50 = 24.0 mg/kg. These findings indicate that RG 6866 is an inhibitor of 5-LOX both in vitro and in vivo.
白三烯C4、D4和E4由花生四烯酸生成依赖于5-脂氧合酶(5-LOX)的活性。本研究测定了RG 6866(N-甲基-4-苄氧基苯基乙酰氧肟酸)对豚鼠5-LOX体外和体内活性的影响。分离的豚鼠腹腔多形核(PMN)细胞由花生四烯酸生成5-羟基-6,8,11,14-二十碳四烯酸(5-HETE)的过程,在与RG 6866共同孵育时受到抑制(IC50 = 0.20微摩尔)。当在PMN的上清液组分中测定5-HETE生成时,观察到类似的效果(IC50 = 0.23微摩尔)。此外,该化合物不抑制3H-LTD4与豚鼠细胞膜的结合。在预先用吲哚美辛、普萘洛尔和吡苄明处理的主动致敏豚鼠中,口服给药后,RG 6866以剂量依赖的方式抑制抗原诱导的全身过敏反应和LTD4依赖性支气管收缩。在肺过敏反应模型中,在用RG 6866(50毫克/千克灌胃)处理后30分钟内观察到死亡率显著(p < 0.05)降低,并持续4小时。最后,口服给药的RG 6866抑制这些动物体内LTC4的形成,ED50 = 24.0毫克/千克。这些发现表明,RG 6866在体外和体内均为5-LOX的抑制剂。